Draper Asset Management, LLC Crispr Therapeutics Ag Call Options Transaction History

Draper Asset Management, LLC

  • $139 Million
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$38.62 - $72.18 $38,620 - $72,180
1,000 Added 58.82%
2,700 $169,000
Q1 2023

May 05, 2023
SELL
$41.0 - $56.12 $24,600 - $33,672
-600 Reduced 26.09%
1,700 $76,000
Q4 2022

Feb 08, 2023
BUY
$39.19 - $65.67 $90,137 - $151,041
2,300 New
2,300 $93,000
Q2 2022

Aug 12, 2022
BUY
$43.23 - $73.83 $86,460 - $147,660
2,000 Added 666.67%
2,300 $31,000
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $21,027 - $33,387
300 New
300 $3,000

Others Institutions Holding CRSP

# of Institutions
505
Shares Held
57.3M
Call Options Held
1.74M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.93B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Draper Asset Management, LLC Portfolio

Follow Draper Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Draper Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email